Liminatus Pharma LIMN
NASDAQ LIMN
$3.84 -0.07 (-1.79%)
As of: Sep 30, 2026 · 9:49 AM EDT

Liminatus Pharma (LIMN) Receivables - Other (2024 - 2025)

Updated

Liminatus Pharma (LIMN) recorded Receivables - Other of $126,275 in Q3 2025, unchanged from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Receivables - Other (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Liminatus Pharma 4.78 Mn 4.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 126,275.00
Jun 30, 2025 126,275.00
Dec 31, 2024 126,275.00
API Access

Liminatus Pharma Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=LIMN&period=max&api_key=YOUR_API_KEY